Global Patent Index - EP 2295023 A1

EP 2295023 A1 20110316 - Flavivirus vaccines

Title (en)

Flavivirus vaccines

Title (de)

Flavivirus Impfstoffe

Title (fr)

Vaccins contre les flavivirus

Publication

EP 2295023 A1 20110316 (EN)

Application

EP 10013094 A 20030115

Priority

  • EP 03748884 A 20030115
  • US 34894902 P 20020115
  • US 38528102 P 20020531

Abstract (en)

The invention provides flavivirus vaccines and methods of making and using these vaccines.

IPC 8 full level

A61K 6/00 (2006.01); A61K 39/12 (2006.01); A61P 31/14 (2006.01); C07K 14/18 (2006.01); C12N 7/00 (2006.01); C12N 7/04 (2006.01); C12N 15/09 (2006.01); C12Q 1/70 (2006.01)

CPC (source: EP KR US)

A61K 39/12 (2013.01 - KR US); A61K 39/395 (2013.01 - KR); A61P 31/14 (2017.12 - EP); C07K 14/005 (2013.01 - EP US); C12N 7/00 (2013.01 - EP US); A61K 2039/5254 (2013.01 - EP US); C12N 2770/24122 (2013.01 - EP US); C12N 2770/24134 (2013.01 - US); C12N 2770/24162 (2013.01 - EP US); Y02A 50/30 (2017.12 - EP US)

Citation (applicant)

  • US 9803894 W 19980302
  • US 5173418 A 19921222 - MOLIN SOREN [DK], et al
  • US 34856502 P 20020115
  • GUBLER: "Dengue and Dengue Hemorrhagic Fever", 22 January 1997, CABI PUBL.
  • BURKE ET AL., AM J. TROP. MED. HYG., vol. 38, 1988, pages 172 - 180
  • HALSTEAD: "Dengue and Dengue Hemorrhagic Fever", 1997, CABI PUBL., pages: 23 - 4,4
  • MONATH: "Vaccines", 1999, SAUNDERS, article "Yellow Fever", pages: 815 - 879
  • AMBERG ET AL., J. VIROL., vol. 73, 1999, pages 8083 - 8094
  • RICE: "Virology", vol. 1, 1995, RAVEN-LIPPINCOTT, article "Flaviviridae", pages: 937
  • SUMIYOSHI ET AL., VIROLOGY, vol. 161, 1987, pages 497 - 510
  • REY ET AL., NATURE, vol. 375, 1995, pages 291 - 298
  • CHAMBERS ET AL., J. VIROL, vol. 73, 1999, pages 3095 - 3101
  • YASUMURA ET AL., NIHON RINSHO, vol. 21, 1963, pages 1201 - 1215
  • "Remington's Pharmaceutical Sciences", 1990, MACK PUBLISHING CO.
  • GRESIKOVA ET AL.: "The Arboviruses, Ecology and Epidemiology", vol. 4, 1988, CRC PRESS, article "Tick-bome Encephalitis", pages: 177 - 203
  • MORRIS-DOWNES ET AL., VACCINE, vol. 19, 2001, pages 3877 - 3884
  • XIONG ET AL., SCIENCE, vol. 243, 1991, pages 1188 - 1191
  • BRAY ET AL., PROC. NATL. ACAD. SCI. U.S.A., vol. 88, 1991, pages 10342 - 10346
  • CHAMBERS ET AL., J. VIROL., vol. 73, 1999, pages 3095 - 3101
  • GUIRAKHOO ET AL., J. VIROL., vol. 75, 2001, pages 7290 - 7304
  • HUANG ET AL., J. VIROL., vol. 74, 2000, pages 3020 - 3028
  • ARROYO ET AL., J. VIROL., vol. 75, 2001, pages 934 - 942
  • LEVENBOOK ET AL., J. BIOL. STAND., vol. 15, 1987, pages 305 - 313
  • MONATH ET AL., J. VIROL., vol. 74, 2000, pages 1742 - 1751
  • REED ET AL., AM. J. HYG., vol. 27, 1938, pages 493 - 497
  • WANG ET AL., J. GEN. VIROL., vol. 76, 1995, pages 2749 - 2755
  • MONATH ET AL., VACCINE, vol. 17, 1999, pages 1869 - 1882
  • CECILIA ET AL., VIROLOGY, vol. 181, 1991, pages 70 - 77
  • MONATH ET AL., CURR. DRUGS- INFECT DIS., vol. 1, 2001, pages 37 - 50
  • MONATH ET AL., VACCINE, vol. 17, 1999, pages 1869 - L882
  • MONATH ET AL., CURR. DRUGS INFECT DIS., vol. 1, 2001, pages 37 - 50
  • LEVENBOOK ET AL., J. BIOL STAND., vol. 15, 1987, pages 305 - 313
  • "Requirements for Biological Substances", vol. 872, 1995, WHO TECH. REP. SER., article "Requirements for yellow fever vaccine", pages: 31 - 68
  • THEILER: "Yellow Fever", vol. 46, 1951, MCGRAW HILL, article "The Virus", pages: 136

Citation (search report)

  • [I] WO 0139802 A1 20010607 - ORAVAX INC [US]
  • [I] DOS SANTOS CLAUDIA NUNES DUARTE ET AL: "Determinants in the envelope E protein and viral RNA helicase NS3 that influence the induction of apoptosis in response to infection with dengue type 1 virus", VIROLOGY, vol. 274, no. 2, 1 September 2000 (2000-09-01), pages 292 - 308, XP004435931, ISSN: 0042-6822
  • [I] LEE E ET AL: "Changes in the Dengue Virus Major Envelope Protein on Passaging and Their Localization on the Three-Dimensional Structure of the Protein", VIROLOGY, ACADEMIC PRESS,ORLANDO, US, vol. 232, no. 2, 9 June 1997 (1997-06-09), pages 281 - 290, XP004452235, ISSN: 0042-6822
  • [I] BRAY MICHAEL ET AL: "Genetic determinants responsible for acquisition of dengue type 2 virus mouse neurovirulence", JOURNAL OF VIROLOGY, vol. 72, no. 2, February 1998 (1998-02-01), pages 1647 - 1651, XP002313125, ISSN: 0022-538X
  • [AD] GUIRAKHOO F ET AL: "CONSTRUCTION,SAFETY,AND IMMUNOGENICITY IN NONHUMAN PRIMATES OF A CHIMERIC YELLOW FEVER-DENGUE VIRUS TETRAVALENT VACCINE", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 75, no. 10, 1 August 2001 (2001-08-01), pages 7290 - 7304, XP002961663, ISSN: 0022-538X, DOI: 10.1128/JVI.75.16.7290-7304.2001
  • [T] GUIRAKHOO F ET AL: "A single amino acid substitution in the envelope protein of chimeric yellow fever-dengue 1 vaccine virus reduces neurovirulence for suckling mice and viremia/viscerotropism for monkeys.", JOURNAL OF VIROLOGY. SEP 2004, vol. 78, no. 18, September 2004 (2004-09-01), pages 9998 - 10008, XP009042435, ISSN: 0022-538X
  • [A] ARROYO J ET AL: "Molecular basis for attenuation of neurovirulence of a yellow fever virus/Japanese encephalitis virus chimera vaccine (chimerivax-je)", JOURNAL OF VIROLOGY, THE AMERICAN SOCIETY FOR MICROBIOLOGY, US, vol. 75, no. 2, January 2001 (2001-01-01), pages 934 - 942, XP002967301, ISSN: 0022-538X
  • [A] CHEN LI-KUANG ET AL: "Generation and characterization of organ-tropism mutants of Japanese encephalitis virus in vivo and in vitro", VIROLOGY, vol. 223, no. 1, 1996, pages 79 - 88, XP002313126, ISSN: 0042-6822
  • [AP] MONATH THOMAS P ET AL: "Single mutation in the flavivirus envelope protein hinge region increases neurovirulence for mice and monkeys but decreases viscerotropism for monkeys: Relevance to development and safety testing of live, attenuated vaccines", JOURNAL OF VIROLOGY, vol. 76, no. 4, February 2002 (2002-02-01), pages 1932 - 1943, XP002313127, ISSN: 0022-538X

Designated contracting state (EPC)

AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT SE SI SK TR

DOCDB simple family (publication)

WO 03103571 A2 20031218; WO 03103571 A3 20040422; AU 2003267937 A1 20031222; AU 2003267937 B2 20080918; AU 2003267937 C1 20190808; BR 0306905 A 20050412; BR 122018075729 B1 20200211; BR 122018075729 B8 20210727; BR 122018075730 B1 20220419; BR PI0306905 B1 20190507; BR PI0306905 B8 20210525; CA 2473321 A1 20031218; CA 2473321 C 20151006; CN 103555669 A 20140205; CN 103555669 B 20171013; EP 1471873 A2 20041103; EP 1471873 A4 20050316; EP 2295023 A1 20110316; EP 3679915 A1 20200715; EP 3679915 B1 20220601; ES 2924640 T3 20221010; FR 23C1005 I1 20230324; IL 163001 A 20121231; IL 223457 A0 20130203; IL 223457 A 20170731; IL 223458 A0 20130203; JP 2005519639 A 20050707; JP 2010268804 A 20101202; JP 5554646 B2 20140723; KR 101074175 B1 20111014; KR 101194818 B1 20121025; KR 20040078666 A 20040910; KR 20110013494 A 20110209; MX PA04006870 A 20050516; NZ 534159 A 20070330; US 10172929 B2 20190108; US 2008274142 A1 20081106; US 2009191240 A1 20090730; US 2013189306 A1 20130725; US 2015024004 A1 20150122; US 2019192649 A1 20190627; US 7459160 B2 20081202; US 8852914 B2 20141007

DOCDB simple family (application)

US 0301214 W 20030115; AU 2003267937 A 20030115; BR 0306905 A 20030115; BR 122018075729 A 20030115; BR 122018075730 A 20030115; CA 2473321 A 20030115; CN 201210162177 A 20030115; EP 03748884 A 20030115; EP 10013094 A 20030115; EP 20159597 A 20030115; ES 20159597 T 20030115; FR 23C1005 C 20230112; IL 16300104 A 20040713; IL 22345712 A 20121205; IL 22345812 A 20121205; JP 2004510692 A 20030115; JP 2010152899 A 20100705; KR 20047011000 A 20030115; KR 20107028588 A 20030115; MX PA04006870 A 20030115; NZ 53415903 A 20030115; US 201213668819 A 20121105; US 201414507319 A 20141006; US 201816199831 A 20181126; US 32586408 A 20081201; US 34503603 A 20030115